Paper697353
In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
DiPersio JR and 1 other. Antimicrob Agents Chemother, 1978. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli. Papers, record 697353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/697353
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Erythromycin | Major topic |
| Flavobacterium | Major topic |
| Gram-Negative Aerobic Bacteria | Major topic |
| Leucomycins | Major topic |
| Microbial Sensitivity Tests |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 409,345 | In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/409345 | PubMed |
| 2 | 332,074 | Rosamicin--a new drug for the treatment of bacterial prostatitis. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/332074 | PubMed |
| 3 | 900,921 | Rosamicin in urethral and vaginal secretions and tissues in dogs and rats. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/900921 | PubMed |
| 4 | 984,752 | In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984752 | PubMed |
| 5 | 984,811 | Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984811 | PubMed |
| 6 | 4,486,485 | Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic. | J Antibiot (Tokyo) | 1972 | https://conductscience.org/library/papers/4486485 | PubMed |
| 7 | 4,840,436 | Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4840436 | PubMed |
| 8 | 4,647,834 | A new Micromonospora-produced macrolide antibiotic, rosamicin. | J Antibiot (Tokyo) | 1972 | https://conductscience.org/library/papers/4647834 | PubMed |
| 9 | 1,267,432 | Rosamicin: in vitro activity against anaerobes and comparison with erythromycin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1267432 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/697353
GET https://conductscience.org/api/papers/v1/697353/authors